BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2939598)

  • 1. Biological significance of Ss (serum soluble) HLA-class I antigens in bone marrow transplantation.
    Tsuji K; Kusama M; Nakatsuji T; Kato S
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):169-74. PubMed ID: 2939598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum HLA class I antigen levels in allogeneic bone marrow transplantation: a possible marker of acute GVHD.
    Puppo F; Brenci S; Ghio M; Bignardi D; Contini P; Bacigalupo A; Van Lint MT; Scudeletti M; Ferrone S; Indiveri F
    Bone Marrow Transplant; 1996 May; 17(5):753-8. PubMed ID: 8733693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-host disease following transplantation of 'one log' versus 'two log' T-lymphocyte-depleted bone marrow from HLA-identical donors.
    Löwenberg B; Wagemaker G; van Bekkum DW; Sizoo W; Sintnicolaas K; Hendriks WD; Hagenbeek A
    Bone Marrow Transplant; 1986 Dec; 1(2):133-40. PubMed ID: 3332128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.
    Kohler PC; Erickson C; Finlay JL; Trigg ME; Edwards B; Hong R; Hank JA; Billing R; Bozdech M; Sondel PM
    Cancer Res; 1986 Oct; 46(10):5413-8. PubMed ID: 3530439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation.
    Le Deist F; Raffoux C; Griscelli C; Fischer A
    J Immunol; 1987 Jan; 138(2):423-7. PubMed ID: 3540121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of soluble HLA class I molecules in children in bone marrow transplantation].
    Sedivá A; Starý J; Hromadníková I; Skalická A; Ghio M
    Cas Lek Cesk; 2000 Oct; 139(20):630-4. PubMed ID: 11192758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
    van Dijk AM; Kessler FL; Verdonck LF; Stadhouders-Keet SA; van Lier RA; de Gast GC; Otten HG
    Br J Haematol; 2000 Dec; 111(3):791-6. PubMed ID: 11122139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotyping analysis of HLA-class II and III genes in unrelated bone marrow transplantation among Japanese. Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank.
    Mizuno S; Ohta H; Kamijima S; Kato Y; Maruya E; Saji H; Kamiya T; Kodera Y; Morishima Y
    Transplant Proc; 1995 Feb; 27(1):1383-4. PubMed ID: 7878921
    [No Abstract]   [Full Text] [Related]  

  • 12. Frequency analysis of cytotoxic T lymphocyte precursors in search for donors in bone marrow transplantation.
    Cukrová V; Dolezalová L; Loudová M; Matĕjková E; Korínková P; Lukásová M; Starý J
    Neoplasma; 1995; 42(1):3-8. PubMed ID: 7617071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the mixed lymphocyte culture reaction in predicting acute graft-versus-host disease after marrow transplants from haploidentical and unrelated donors.
    Mickelson EM; Anasetti C; Yoon Choo S; Longton GM; Petersdorf EW; Martin PJ; Hansen JA
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1239-40. PubMed ID: 8442101
    [No Abstract]   [Full Text] [Related]  

  • 14. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mixed lymphocyte culture as a compatibility test for bone marrow transplantation].
    Hajek-Rosenmayr A
    Wien Klin Wochenschr; 1986 Jan; 98(2):44-9. PubMed ID: 2938340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients.
    Dickinson AM; Sviland L; Hamilton PJ; Usher P; Taylor P; Jackson G; Dunn J; Proctor SJ
    Bone Marrow Transplant; 1994 Jan; 13(1):65-70. PubMed ID: 8019455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistological study of human hepatic graft-versus-host disease.
    Dilly SA; Sloane JP
    Clin Exp Immunol; 1985 Dec; 62(3):545-53. PubMed ID: 3910317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
    Liem LM; Koelman CA; Doxiadis II; van Houwelingen JC; Goulmy E; Claas FH
    Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
    Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.